Compile Data Set for Download or QSAR
maximum 50k data
Found 159 of ph data with Target = 'Somatostatin receptor type 4'
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144752(US8952128, 11)
Affinity DataKi:  2.10nM ΔG°:  -49.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  3.20nM ΔG°:  -48.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144768(US8952128, 27)
Affinity DataKi:  7.30nM ΔG°:  -46.4kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144748(US8952128, 7)
Affinity DataKi:  10.8nM ΔG°:  -45.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144751(US8952128, 10)
Affinity DataKi:  20.6nM ΔG°:  -43.9kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144750(US8952128, 9)
Affinity DataKi:  24nM ΔG°:  -43.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144741(US8952128, 5)
Affinity DataKi:  25.2nM ΔG°:  -43.4kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144749(US8952128, 8)
Affinity DataKi:  60.7nM ΔG°:  -41.2kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144742(US8952128, 6)
Affinity DataKi:  61.9nM ΔG°:  -41.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144740(US8952128, 4)
Affinity DataKi:  93.5nM ΔG°:  -40.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275985(US10071974, Example 96 | US10577336, Example 96)
Affinity DataEC50:  13nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275986(US10071974, Example 97 | US10577336, Example 97)
Affinity DataEC50:  40.8nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275987(US10071974, Example 98)
Affinity DataEC50:  85.3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275988(US10071974, Example 99 | US10577336, Example 99)
Affinity DataEC50:  43.4nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275989(US10071974, Example 100 | US10577336, Example 100)
Affinity DataEC50:  103nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275990(US10071974, Example 101 | US10071974, Example 103 ...)
Affinity DataEC50:  6.5nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275991(US10071974, Example 102 | US10577336, Example 102)
Affinity DataEC50:  31nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275990(US10071974, Example 101 | US10071974, Example 103 ...)
Affinity DataEC50:  60.7nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275993(US10071974, Example 104 | US10577336, Example 104)
Affinity DataEC50:  73.5nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275994(US10071974, Example 105 | US10577336, Example 105)
Affinity DataEC50:  596nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275995(US10071974, Example 106 | US10577336, Example 106)
Affinity DataEC50:  230nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275996(US10071974, Example 107 | US10577336, Example 107)
Affinity DataEC50:  51.1nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275997(US10071974, Example 108 | US10577336, Example 108)
Affinity DataEC50:  58.1nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275998(US10071974, Example 109 | US10577336, Example 109)
Affinity DataEC50:  3.70nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275999(US10071974, Example 110 | US10071974, Example 111 ...)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM275999(US10071974, Example 110 | US10071974, Example 111 ...)
Affinity DataEC50:  290nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276001(US10071974, Example 112 | US10071974, Example 113 ...)
Affinity DataEC50:  5.50E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276001(US10071974, Example 112 | US10071974, Example 113 ...)
Affinity DataEC50:  380nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276003(US10071974, Example 114 | US10071974, Example 115 ...)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276003(US10071974, Example 114 | US10071974, Example 115 ...)
Affinity DataEC50:  294nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276005(US10071974, Example 116 | US10071974, Example 117 ...)
Affinity DataEC50:  9.30nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276005(US10071974, Example 116 | US10071974, Example 117 ...)
Affinity DataEC50:  2.60nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276005(US10071974, Example 116 | US10071974, Example 117 ...)
Affinity DataEC50:  86.8nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276008(US10071974, Example 119 | US10071974, Example 120 ...)
Affinity DataEC50:  73.9nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276008(US10071974, Example 119 | US10071974, Example 120 ...)
Affinity DataEC50:  5.90nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276010(US10071974, Example 121 | US10071974, Example 122 ...)
Affinity DataEC50:  11.1nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276010(US10071974, Example 121 | US10071974, Example 122 ...)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276012(US10071974, Example 123 | US10071974, Example 124 ...)
Affinity DataEC50:  32.4nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276012(US10071974, Example 123 | US10071974, Example 124 ...)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276012(US10071974, Example 123 | US10071974, Example 124 ...)
Affinity DataEC50:  16.4nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276015(US10071974, Example 126 | US10071974, Example 127 ...)
Affinity DataEC50:  46nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276015(US10071974, Example 126 | US10071974, Example 127 ...)
Affinity DataEC50:  1.00E+3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276017(US10071974, Example 128 | US10071974, Example 129 ...)
Affinity DataEC50:  5nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276017(US10071974, Example 128 | US10071974, Example 129 ...)
Affinity DataEC50:  5.30nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276017(US10071974, Example 128 | US10071974, Example 129 ...)
Affinity DataEC50:  466nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276020(US10071974, Example 131 | US10071974, Example 132 ...)
Affinity DataEC50:  19nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276020(US10071974, Example 131 | US10071974, Example 132 ...)
Affinity DataEC50:  1.00E+4nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276022(US10071974, Example 133 | US10071974, Example 134 ...)
Affinity DataEC50:  55.3nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276022(US10071974, Example 133 | US10071974, Example 134 ...)
Affinity DataEC50:  98.1nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM276024(US10071974, Example 135 | US10071974, Example 136 ...)
Affinity DataEC50:  8.5nMpH: 7.4 T: 2°CAssay Description:Compounds are dissolved and diluted in DMSO. The final test solution contains 1% DMSO. The cAMP standard (Lance cAMP 384 Kit; PerkinElmer, Cat# AD026...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 159 total ) | Next | Last >>
Jump to: